IRIS Accounts Production v23.3.0.418 13938556 director 24.2.22 28.2.23 28.2.23 false true false false true false Ordinary 1.00000 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure139385562022-02-23139385562023-02-28139385562022-02-242023-02-28139385562022-02-2313938556ns16:EnglandWales2022-02-242023-02-2813938556ns15:PoundSterling2022-02-242023-02-2813938556ns11:Director12022-02-242023-02-2813938556ns11:PrivateLimitedCompanyLtd2022-02-242023-02-2813938556ns11:SmallEntities2022-02-242023-02-2813938556ns11:AuditExempt-NoAccountantsReport2022-02-242023-02-2813938556ns11:SmallCompaniesRegimeForDirectorsReport2022-02-242023-02-2813938556ns11:SmallCompaniesRegimeForAccounts2022-02-242023-02-2813938556ns11:FullAccounts2022-02-242023-02-2813938556ns11:OrdinaryShareClass12022-02-242023-02-28139385561ns11:OrdinaryShareClass12022-02-242023-02-2813938556ns11:RegisteredOffice2022-02-242023-02-2813938556ns6:CurrentFinancialInstruments2023-02-2813938556ns6:ShareCapital2023-02-2813938556ns6:RetainedEarningsAccumulatedLosses2023-02-2813938556ns6:FurnitureFittings2022-02-242023-02-2813938556ns6:FurnitureFittings2023-02-2813938556ns6:WithinOneYearns6:CurrentFinancialInstruments2023-02-2813938556ns11:OrdinaryShareClass12023-02-2813938556ns6:RetainedEarningsAccumulatedLosses2022-02-242023-02-28
REGISTERED NUMBER: 13938556 (England and Wales)















Morio-Labs Limited

Unaudited Financial Statements

for the period

24 February 2022 to 28 February 2023






Morio-Labs Limited (Registered number: 13938556)

Contents of the Financial Statements
for the period 24 February 2022 to 28 February 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Morio-Labs Limited

Company Information
for the period 24 February 2022 to 28 February 2023







Director: Ms A Morinaga





Registered office: First Floor
38 Thurloe Place
London
SW7 2HP





Registered number: 13938556 (England and Wales)





Accountants: Haines Watts South East LLP
Chartered Accountants
New Derwent House
69-73 Theobalds Road
London
WC1X 8TA

Morio-Labs Limited (Registered number: 13938556)

Balance Sheet
28 February 2023

Notes £ £
Fixed assets
Tangible assets 4 20,074

Current assets
Stocks 176,163
Debtors 5 896
Cash at bank 47,042
224,101
Creditors
Amounts falling due within one year 6 302,570
Net current liabilities (78,469 )
Total assets less current liabilities (58,395 )

Capital and reserves
Called up share capital 7 100
Retained earnings 8 (58,495 )
Shareholders' funds (58,395 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 28 February 2023.

The members have not required the company to obtain an audit of its financial statements for the period ended 28 February 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 14 November 2023 and were signed by:





Ms A Morinaga - Director


Morio-Labs Limited (Registered number: 13938556)

Notes to the Financial Statements
for the period 24 February 2022 to 28 February 2023


1. Statutory information

Morio-Labs Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. Accounting policies

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Going concern
The company meets its day to day working capital requirements through the support of the directors and shareholders of the company. On this basis, the directors consider it appropriate to prepare the financial statements on the going concern basis.

3. Employees and directors

The average number of employees during the period was 2 .

4. Tangible fixed assets
Fixtures
and
fittings
£
Cost
Additions 26,765
At 28 February 2023 26,765
Depreciation
Charge for period 6,691
At 28 February 2023 6,691
Net book value
At 28 February 2023 20,074

5. Debtors: amounts falling due within one year
£
Trade debtors 796
Other debtors 100
896

Morio-Labs Limited (Registered number: 13938556)

Notes to the Financial Statements - continued
for the period 24 February 2022 to 28 February 2023


6. Creditors: amounts falling due within one year
£
Trade creditors 62,461
Amounts owed to group undertakings 233,812
Taxation and social security 3,417
Other creditors 2,880
302,570

7. Called up share capital

Allotted, issued and fully paid:
Number: Class: Nominal
value: £
100 Ordinary £1 100

100 Ordinary shares of £1 each were allotted and fully paid for cash at par during the period.

8. Reserves
Retained
earnings
£

Deficit for the period (58,495 )
At 28 February 2023 (58,495 )